Clinical trial No longer in our active list Interventional Ages 16 and up Women only

Measuring heart function in pregnant women using non-invasive techniques

Official title: Cardiac Flow Measurements in Pregnant Women by Non Invasive Techniques: Comparison Between USCOM, ICON and Trans Thoracic Echography

Run by University of Geneva, Switzerland · NCT06114147 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing two new non-invasive heart monitoring techniques in pregnant women to see how well they measure heart function compared to the standard ultrasound method.

Quick facts

Study typeInterventional
Ages16 Years and up
SexWomen only
Enrollment150 (estimated)
SponsorUniversity of Geneva, Switzerland
Academic / other
Locations1 site (Geneve)
Trial IDNCT06114147 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant individuals over 16 years old attending prenatal consultations at the Geneva University Hospitals.

Probably not a fit

Patients with preexisting or congenital heart conditions or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to compare the effectiveness of new non-invasive techniques, the Index of Contractility Monitor (ICON) and the Ultra Sonic Cardiac Output Monitor (USCOM), in measuring cardiac output, systolic ejection volume, and vascular filling in pregnant women. The study will assess these measurements against the gold standard of trans-thoracic ultrasound during the first and third trimesters of pregnancy. Additionally, it will evaluate patient comfort, examination time, and examiner satisfaction with each technique. Participants will be enrolled from the first trimester and monitored until delivery, with specific consultations scheduled for measurements.

Why it matters

Potential benefit: If successful, this study could provide safer and more comfortable methods for monitoring cardiac function in pregnant women.

How similar studies have gone: While the specific combination of techniques in this study may be novel, similar non-invasive approaches have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any pregnant person over 16 years old followed at the prenatal consultation of the maternity ward of the Geneva University Hospitals.

Exclusion Criteria:

* Drug or alcohol abuse,
* Miscarriage or intra uterine demise before the first exam.
* Inability to follow the procedures of the investigation, e.g. due to psychological disorders, dementia, etc. of the subject,
* Inability to give an informed consent.
* preexisting or congenital cardiopathy
* Structural abnormalities of hearth or valves diagnosed in the first Trans Thoracic Echocardiography screening

Where it's running

  • Hopitaux Universitaires de Geneve
    Geneve, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.